Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1950288
Max Phase: Preclinical
Molecular Formula: C56H74N8O15S2
Molecular Weight: 1163.38
Molecule Type: Small molecule
Associated Items:
ID: ALA1950288
Max Phase: Preclinical
Molecular Formula: C56H74N8O15S2
Molecular Weight: 1163.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOC(=O)[C@@H]1O[C@H]1C(=O)N(CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)C1(NC(=O)CCCCCNC(=O)CCCCCN2/C(=C/C=C/C=C/C3=[N+](CC)c4ccc(S(=O)(=O)O)cc4C3(C)C)C(C)(C)c3cc(S(=O)(=O)[O-])ccc32)CC1
Standard InChI: InChI=1S/C56H74N8O15S2/c1-7-61-40-26-24-36(80(72,73)74)33-38(40)54(3,4)43(61)20-12-9-13-21-44-55(5,6)39-34-37(81(75,76)77)25-27-41(39)62(44)31-17-11-15-22-46(66)58-30-16-10-14-23-47(67)59-56(28-29-56)53(71)63-32-18-19-42(63)50(68)60-64(35-45(57)65)51(69)48-49(79-48)52(70)78-8-2/h9,12-13,20-21,24-27,33-34,42,48-49H,7-8,10-11,14-19,22-23,28-32,35H2,1-6H3,(H6-,57,58,59,60,65,66,67,68,72,73,74,75,76,77)/t42-,48+,49+/m0/s1
Standard InChI Key: BFWFEMREEKAKFM-FVKJYKRZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1163.38 | Molecular Weight (Monoisotopic): 1162.4715 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Lee J, Bogyo M.. (2012) Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain., 22 (3): [PMID:22243962] [10.1016/j.bmcl.2011.12.079] |
Source(1):